GHRH-(1-29)-NH2 (human)



GHRH-(1-29)-NH2 (human)

Y1YY1A2AA2D3DD3A4AA4I5II5F6FF6T7TT7N8NN8S9SS9Y10YY10R11RR11K12KK12V13VV13L14LL14G15GG15Q16QQ16L17LL17S18SS18A19AA19R20RR20K21KK21L22LL22L23LL23Q24QQ24D25DD25I26II26M27MM27S28SS28R29RR29

SMILES None
InChIKey KFGRVLINLVVMJA-MITYVQBRSA-N
Sequence YADAIFTNSYRKVLGQLSARKLLQDIMSR

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)


No bioactivity data available.

GHRH-(1-29)-NH2 (human)

Y1YY1A2AA2D3DD3A4AA4I5II5F6FF6T7TT7N8NN8S9SS9Y10YY10R11RR11K12KK12V13VV13L14LL14G15GG15Q16QQ16L17LL17S18SS18A19AA19R20RR20K21KK21L22LL22L23LL23Q24QQ24D25DD25I26II26M27MM27S28SS28R29RR29

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.